Navigation Links
PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results
Date:10/27/2009

ments had a favorable impact on earnings per share of approximately two cents in the current quarter.

On a segment basis, consolidated service revenue for the first quarter of Fiscal Year 2010 was $202.3 million in Clinical Research Services (CRS), $28.8 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $28.7 million in Perceptive Informatics, Inc.

Backlog at the end of September was approximately $2.157 billion. The reported backlog included gross new business wins of $322.1 million, cancellations of $100.7 million, a positive impact from foreign exchange rates of $21.7 million, and a negative impact from other adjustments of $2.4 million. The net book-to-bill ratio (defined as gross new business less cancellations divided by service revenue) was approximately 0.85 in the quarter. On a year-over-year basis, backlog at September 30, 2009 was up 4.7%.

Mr. Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer stated, "Despite a difficult market environment for both our industry and our Company, we were able to exceed our EPS expectations. Client mergers and portfolio reprioritizations have created some unevenness in the demand for our services as reflected in project proposal flow and time to award. At the same time, there appear to be promising signs of stabilization, and we continue to believe that we are a key solution to many of the challenges that our client industries face."

Mr. von Rickenbach continued, "Most importantly, we are focused on the future and are optimistic about what it holds for PAREXEL. After many years, we have achieved our goal of establishing a comprehensive global presence to better serve our clients. As part of our ongoing efforts to leverage these resources more strategically, we will be realigning our global cost structure to further capitalize upon the value that is inherent in our worldwide infrastructure. We believe that these steps will str
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
2. PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
3. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
4. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
5. PAREXEL Expands Global Clinical Pharmacology Capabilities
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
8. NxStage(R) Reports Significant Interim FREEDOM Study Results
9. Hospira Reports Third-Quarter 2009 Results
10. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
11. Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
(Date:1/23/2015)... , January 23, 2015 Heptares Therapeutics, ... delighted to announce that the Malcolm Campbell Memorial ... (Vice President of Chemistry), Fiona Marshall (Chief ... Executive Officer and co-founder) for the seminal contributions to GPCR ...
(Date:1/22/2015)... , Jan. 22, 2015  BiOptix is pleased to announce ... Vice President of Chemistry and Biochemistry. Scott joins the company ... Pharmaceuticals, and Amgen throughout the course of his nearly ... "Scott is a nationally recognized thought leader in ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... Corporation (Nasdaq: DNDN ) announced today that ... remainder of its New Jersey manufacturing facility, allowing the ... to help meet the needs of patients with asymptomatic ... cancer.   Last April, upon receiving FDA ...
... Hospital and SynCardia Systems, Inc. announced today that Texas ... complete the first phase of certification to implant the ... use the Total Artificial Heart as a bridge to ... as children and now require mechanical support as a ...
Cached Medicine Technology:Dendreon Expands Launch of PROVENGE 2Dendreon Expands Launch of PROVENGE 3Dendreon Expands Launch of PROVENGE 4Dendreon Expands Launch of PROVENGE 5Texas Children's Is First Pediatric Hospital To Begin Certification Process for SynCardia's Total Artificial Heart 2Texas Children's Is First Pediatric Hospital To Begin Certification Process for SynCardia's Total Artificial Heart 3
(Date:1/23/2015)... AZ (PRWEB) January 23, 2015 Hastings and ... injury matters, reports a record number of legal representation client ... speaking, there has been a steady rise in the number ... work and at home throughout the Valley. With that said, ... accident be reviewed by an experienced law firm. Hastings and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Liberty University has ... (M.A.) program from the Council for Accreditation of ... part of Liberty’s Center for Counseling & Family Studies ... dean of the university’s new School of Behavioral Sciences. Prior ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located in ... number one best large hotel for families in the United ... annual Travelers’ Choice Awards. , TripAdvisor represents the world’s ... to millions of unbiased and honest traveler reviews. The best ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader ... designers are thrilled to have it lead the wedding dress ... collection of prom dresses for the global market. , “The ... vision and he focuses on continuing the goal of operational ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Reports a Record Number of Client Review Requests for Slip and Fall Accidents in 2014 2Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2
... be very high , , WEDNESDAY, Sept. 26 (HealthDay News) ... as Tylenol), taken together, could lead to liver damage, ... that,s toxic to the organ, researchers from the University ... not only by drinking caffeine while taking acetaminophen, the ...
... the Largest Independent Ecolabel in the U.S., ... GS-8, Green Seal,s Environmental Standard for Household Cleaners.,The ... ever-increasing,discoveries about the detrimental effects of certain chemicals ... last year that GS-8 required,revision. Now available to ...
... Industry Advisors and ... ... Inc., developers,of the G-Trainer anti-gravity treadmill, today announced advisor,relationships with ... treadmill manufacturer. Alter-G,s anti-gravity treadmill, the G-Trainer, enables users ...
... Chaka Fattah votes in favor of health insurance for low-income ... ... Congressman Chaka,Fattah (D-PA) joined with a bi-partisan coalition of his colleagues ... income,children. "For years I have been a supporter of both The ...
... 25 Gentiva Health,Services, Inc. (Nasdaq: GTIV ... and related services, today announced that it has,filed ... and,Exchange Commission (SEC) for the periodic offering and ... preferred stock, common stock and warrants,after the SEC ...
... 25 Haemonetics,Corporation CEO, Brad Nutter, will be ... September 26, 2007 at 2:30 pm. Mr. Nutter,s,presentation ... The webcast will be,available for replay through October ... During the presentation, Mr. Nutter will give an ...
Cached Medicine News:Health News:Caffeine Plus Acetaminophen Toxic for Some 2Health News:Green Seal Ramps Up Environmental Standard for Household Cleaners 2Health News:Alter-G Forging New Relationships 2Health News:Alter-G Forging New Relationships 3Health News:Gentiva(R) Health Services Files Universal Shelf Registration Statement 2Health News:Gentiva(R) Health Services Files Universal Shelf Registration Statement 3Health News:Haemonetics' Webcast Presentation 2
The compact, simple-to-use ECG for medical professionals....
The Wills Eye Manual, Fourth Edition has been updated to include the newest drugs, procedures, and treatment protocols. Clinicians will have instant access to current information on diagnosis and tre...
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
The ideal on-the-spot reference for residents and practitioners seeking fast facts on fracture management....
Medicine Products: